Judith Thierry, DO in San Fidel, NM - General Practice

Judith Thierry, DO is a General Practice physician based in San Fidel, New Mexico. Judith Thierry is licensed to practice in Michigan (license number 5101008729) and her current practice location is Exit 102 Off I-40 1/2 Mi South, San Fidel, New Mexico. She can be reached at her office (for appointments etc.) via phone at (505) 552-5385.

NPI number for Judith Thierry is 1881870426 and her current mailing address is Po Box 130, San Fidel, New Mexico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1881870426.

Contact Information

	Judith Thierry, DO
	Exit 102 Off I-40 1/2 Mi South, San Fidel, NM 87049-0130
	(505) 552-5385
	(505) 552-5473

Physician's Profile

Full Name	Judith Thierry
Gender	Female
Speciality	General Practice
Location	Exit 102 Off I-40 1/2 Mi South, San Fidel, New Mexico
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1881870426
Provider Enumeration Date: 01/14/2008
Last Update Date: 01/14/2008

Medical Identifiers

Medical identifiers for Judith Thierry such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881870426	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	5101008729 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Judith Thierry is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Judith Thierry, DO Po Box 130, San Fidel, NM 87049-0130 Ph: (505) 552-5385	Judith Thierry, DO Exit 102 Off I-40 1/2 Mi South, San Fidel, NM 87049-0130 Ph: (505) 552-5385

News Archive

Goodwin enters new Biopharmaceutical Development and Manufacturing Agreement with multinational client

Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.

New pocket guide offers detailed guidance on treating older adults with mental health issues

Nearly 20 percent of older Americans experience depression and the highest rate of suicide is among older adult Caucasian males.

Researchers to present new results for Merck's allergy immunotherapy tablets at AAAAI meeting

Merck, known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the company's investigational allergy immunotherapy tablets (AITs) for ragweed pollen (Ambrosia artemisiifolia) and grass pollen (Phleum pratense) at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.

NVIC participates in NVAC-sponsored meeting to discuss the U.S. vaccine safety system

The National Vaccine Information Center participated in a meeting sponsored by the federal National Vaccine Advisory Committee and facilitated by The Keystone Center April 11-13 in Salt Lake City to discuss strengthening the U.S. vaccine safety system.

BD Medical announces FDA clearance of BD Intelliport Medication Management System

BD Medical, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today announced that the U.S. Food and Drug Administration has cleared the BD Intelliport Medication Management System, the first-of-its-kind medication management solution for manual IV bolus injections.

Judith Thierry, DO - General Practice in San Fidel, NM